Sanzhuliang Group och Appchem undertecknade ett strategiskt samarbetsavtal (1)

Jun 10, 2025

Lämna ett meddelande

Den 9 mars höll Sanzhuliang Group Co., Ltd. och Appchem ett symposium om strategiskt samarbete och undertecknade ett strategiskt samarbetsavtal. De två parterna hade fördjupade utbyten om ämnen som det djupgående genomförandet av strategin för ett hälsosamt Kina, främjande av en djup integration av artificiell intelligens och hälsoindustrin och främjande av byggandet av en hälsosam Sidenväg. Sun Zhi, Styrelseordförande för Sanzhuliang Group Co., Ltd., och Hu Yongwei, styrelseordförande för Appchem, undertecknade ett strategiskt samarbetsavtal på båda parters vägnar och nådde ett strategiskt partnerskap{9}.

Hu Yongwei, Chairman Of Xi'an App-Chem Bio, Was Invited To Participate in The High-quality Development Symposium Of Listed Companies

Health is linked to the happiness of thousands of households and the future of the country and nation. The Party Central Committee has always placed the protection of people's health in a strategic position of priority development, issued the "Healthy China 2030" Planning Outline, and comprehensively promoted the construction of a healthy China, and the health level of our people has been significantly improved. In 2024, the life expectancy of Chinese residents will reach 79 år, uppnå målen och kraven i "14: e femårsplanen" före schemat .

2025

The 2025 Government Work Report proposed to allocate more funds and resources to invest in people and serve the people's livelihood. Representatives and members of the National People's Congress and the Chinese People's Political Consultative Conference said that it is necessary to insist on putting the safety of people's lives and health first, deepen the reform of the medical and health system, improve the capacity of primary medical and health services, continue to carry out scientific and technological innovation, and protect people's health i alla aspekter och under hela cykeln och sträva efter att skriva ett varmare svarblad för ett friskt Kina .

news-722-420

The implementation of the Healthy China strategy has provided unprecedented development opportunities for the big health industry. The big health industry is based on a beautiful ecological environment, supported by the health product manufacturing industry, and centered on the health service industry. It has the characteristics of wide coverage, long industrial chain, large radiation and driving effect, and strong agglomeration effect. It is one of the strategic emerging Branscher med den största tillväxtpotentialen i världen . Enligt "Health Industry Consumption Trend Development Report" som släppts av China Consumers Association har det kontinuerliga utvecklingen av den friska Kina -strategin lett till att marknadsstorleken för hälsoindustrin expanderar .}

1--6102025

In 2024, the total revenue of China's big health industry will reach 9 trillion yuan, a significant leap compared to the total amount of 8 trillion yuan in 2021. Looking ahead, the concept of "preventing disease before it occurs" is accelerating, primary medical care is constantly strengthening, and the health of the whole people is steadily advancing. All parties have taken joint efforts to jointly outline the Bild av ett friskt Kina som är gemensamt byggt och delat .

The meeting pointed out that Sanzhuliang Group and Appchem have reached a strategic cooperation. The two parties will give full play to their respective comparative advantages in agricultural technology, healthy food, biotechnology, industrial ecology and other fields, and carry out close cooperation around agricultural biotechnology innovation, new functional food and health product research and development, industry standard formulation, enterprise digital transformation, international market Layout och andra aspekter, för att uppnå full chain-integration från fält till laboratorium till marknad, förbättra produktteknologiinnehållet och marknadskonkurrenskraften, gemensamt främja högkvalitativ utveckling av hälsoindustrin och främja implementeringen av den friska Kina-strategin .